Synonyms: | |
Status: | Phase 3 |
Entry Type: | Protein |
Molecule Category: | UNKNOWN |
ATC: | V03AB32 |
UNII: | GAN16C9B8O |
InChI Key | RWSXRVCMGQZWBV-WDSKDSINSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C10H17N3O6S |
Molecular Weight | 307.33 |
AlogP | -2.21 |
Hydrogen Bond Acceptor | 6.0 |
Hydrogen Bond Donor | 6.0 |
Number of Rotational Bond | 9.0 |
Polar Surface Area | 158.82 |
Molecular species | ZWITTERION |
Aromatic Rings | 0.0 |
Heavy Atoms | 20.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Transferase
|
- | 20 | - | - | - | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 67 | |
Transporter
Primary active transporter
ATP-binding cassette
ABCC subfamily
|
- | - | - | - | 10 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Peripheral Nervous System Diseases | 3 | D010523 | ClinicalTrials |
Peripheral Nervous System Diseases | 3 | D010523 | ClinicalTrials |
Pain | 3 | D010146 | ClinicalTrials |
Cystic Fibrosis | 3 | D003550 | ClinicalTrials |
Parkinson Disease | 2 | D010300 | ClinicalTrials |
Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
Reperfusion Injury | 2 | D015427 | ClinicalTrials |
Breast Neoplasms | 2 | D001943 | ClinicalTrials |
Persian Gulf Syndrome | 1 | D018923 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 70-18-8 |
ChEBI | 16856 |
ChEMBL | CHEMBL1543 |
DrugBank | DB00143 |
DrugCentral | 1312 |
EPA CompTox | DTXSID6023101 |
FDA SRS | GAN16C9B8O |
Human Metabolome Database | HMDB0000125 |
Guide to Pharmacology | 6737 |
KEGG | C02471 |
PDB | GSH |
PubChem | 124886 |
SureChEMBL | SCHEMBL9167 |
ZINC | ZINC000003830891 |